Boasting a market cap of $1 trillion, Eli Lilly and Company (LLY) is a major global research-based pharmaceutical company ...

Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its blockbuster ...

Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...

In recent days, Revvity, Inc. updated its outlook for the fourth quarter and full year 2025, guiding to approximately ...

Eli Lilly (LLY) heads into 2026 with GLP-1 pricing and competition risks; oral GLP-1 race heats up and downside looms.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...